Adherence of patients to PAP therapy in whom sleep-disordered breathing was diagnosed during acute hospitalization for heart failure is comparable to that of patients in the ambulatory setting claims a new study in the December 15 issue of the Journal of Clinical Sleep Medicine. Authors suggests adherence to therapy in first 3 months is a predictive marker for improved survival.

Read the study in JCSM: Adherence to Positive Airway Pressure Therapy in Hospitalized Patients with Decompensated Heart Failure and Sleep-Disordered Breathing